BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 29377340)

  • 1. Nuclear pseudoinclusions in melanoma cells: prognostic fact or artifact? The possible role of Golgi phosphoprotein 3 overexpression in nuclear pseudoinclusions generation.
    Donizy P; Kaczorowski M; Biecek P; Halon A; Matkowski R
    Pathol Int; 2018 Feb; 68(2):117-122. PubMed ID: 29377340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoli cytomorphology in cutaneous melanoma cells - a new prognostic approach to an old concept.
    Donizy P; Biecek P; Halon A; Maciejczyk A; Matkowski R
    Diagn Pathol; 2017 Dec; 12(1):88. PubMed ID: 29284501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Golgi-Related Proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in Cutaneous Melanoma: Patterns of Expression and Prognostic Significance.
    Donizy P; Kaczorowski M; Biecek P; Halon A; Szkudlarek T; Matkowski R
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27706081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear Pseudoinclusions and Intranuclear Grooves Have an Important Impact on the Long-term Survival of Patients With Uveal Melanoma.
    Markiewicz A; Donizy P; Elas M; OrŁowska-Heitzmann J; Biecek P; Romanowska-Dixon B
    Anticancer Res; 2021 Jan; 41(1):517-526. PubMed ID: 33419851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of immunohistochemical epithelial-mesenchymal transition markers in skin melanoma patients.
    Pieniazek M; Donizy P; Halon A; Leskiewicz M; Matkowski R
    Biomark Med; 2016 Sep; 10(9):975-85. PubMed ID: 27586584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
    Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
    Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.
    Ladstein RG; Bachmann IM; Straume O; Akslen LA
    J Invest Dermatol; 2012 Apr; 132(4):1247-52. PubMed ID: 22297638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
    Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Golgi Phosphoprotein-3 and Y-Box-Binding Protein-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer.
    Abd El-Maqsoud NM; Osman NA; Abd El-Hamid AM; Fath El-Bab TK; Galal EM
    Clin Genitourin Cancer; 2016 Apr; 14(2):e143-52. PubMed ID: 26794392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral expression of cyclooxygenase-2 (COX-2) is a negative prognostic marker for patients with cutaneous melanoma.
    Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW
    Melanoma Res; 2016 Oct; 26(5):448-56. PubMed ID: 27391144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
    Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
    Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease.
    Thies A; Moll I; Berger J; Wagener C; Brümmer J; Schulze HJ; Brunner G; Schumacher U
    J Clin Oncol; 2002 May; 20(10):2530-6. PubMed ID: 12011132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
    Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS
    Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression.
    Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
    Br J Dermatol; 2013 Sep; 169(3):618-28. PubMed ID: 23662813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High percentage of ADAM-10 positive melanoma cells correlates with paucity of tumor-infiltrating lymphocytes but does not predict prognosis in cutaneous melanoma patients.
    Donizy P; Zietek M; Leskiewicz M; Halon A; Matkowski R
    Anal Cell Pathol (Amst); 2015; 2015():975436. PubMed ID: 26266086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
    Caudron A; Battistella M; Feugeas JP; Pages C; Basset-Seguin N; Mazouz Dorval S; Funck Brentano E; Sadoux A; Podgorniak MP; Menashi S; Janin A; Lebbé C; Mourah S
    Exp Dermatol; 2016 Aug; 25(8):618-22. PubMed ID: 27060463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-Mesenchymal Expression Phenotype of Primary Melanoma and Matched Metastases and Relationship with Overall Survival.
    Yan S; Holderness BM; Li Z; Seidel GD; Gui J; Fisher JL; Ernstoff MS
    Anticancer Res; 2016 Dec; 36(12):6449-6456. PubMed ID: 27919967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of adenylate cyclase-associated protein 2 is a novel prognostic marker in malignant melanoma.
    Masugi Y; Tanese K; Emoto K; Yamazaki K; Effendi K; Funakoshi T; Mori M; Sakamoto M
    Pathol Int; 2015 Dec; 65(12):627-34. PubMed ID: 26374196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GOLPH3 is a potential therapeutic target and a prognostic indicator of poor survival in bladder cancer treated by cystectomy.
    Zhang Q; Zhuang J; Deng Y; Zhao X; Tang B; Yao D; Zhao W; Chang C; Lu Q; Chen W; Zhang S; Ji C; Cao L; Guo H
    Oncotarget; 2015 Oct; 6(31):32177-92. PubMed ID: 26375441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.